Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Chromosome ’Caps’ Predict Bone Marrow Disease

19.04.2004


For the first time, Imperial College London researchers at the Hammersmith Hospital studying a rare bone marrow disease have found an association between ’telomere shortening’ - changes in the lengths of DNA repeats at the end of chromosomes - and the time of development and severity of disease symptoms in patients.



Reporting in Nature Genetics today (18 April 2004), the Hammersmith team, collaborating with scientists at the Washington University School of Medicine in the USA, is hoping that the findings could lead to better screening for this and other diseases, as well as suggest targets for new therapies.

Dyskeratosis congenita (DC) is a rare but serious inherited condition where the body is unable to make adequate numbers of blood cells. It can lead to bone marrow failure and a much higher risk of developing cancer. People with DC also have a mutation in an enzyme (telomerase) which repairs telomeres (sections of DNA repeats which ’cap’ the ends of chromosomes) and as a result, telomere length in their chromosomes is shorter.


In families with a history of a certain type of the disease, autosomal dominant DC, the disease becomes more severe in succeeding generations.

"We found when we looked at the DNA of families that suffer from the disease, the telomere length gave an indication of how soon and how severely patients were likely to get the disease," said Inderjeet Dokal, Professor of Haematology at Imperial College London and one of the authors of the study. "This ’disease anticipation’ was only thought to occur in specific neurological diseases until now."

The researchers propose that the shortening of the DNA repeats in
telomeres may be responsible for disease anticipation. They investigated the telomere lengths and disease status of 27 affected individuals from eight families with the autosomal dominant sub-type of DC and compared this to telomere length measurements in normal families. "The findings of this study provides a novel mechanism for disease anticipation in humans," explains Professor Doka.

Tony Stephenson | alfa
Further information:
http://dx.doi.org/10.1038/ng1346
http://www.innovations-report.com/html/profiles/profile-1221.html

More articles from Life Sciences:

nachricht More genes are active in high-performance maize
19.01.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht How plants see light
19.01.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>